One hundred ten patients with indication of intravenous chemotherapy were randomly assigned to TIVAD implant through US-guided internal jugular vein ( USG ) puncture ( 39 ) or internal jugular vein blindly ( IJB ) ( 36 ) or subclavian vein blindly ( SCB ) ( 35 ) .